Elizabeth M. Brunt - Concepedia

Author

Elizabeth M. Brunt

Washington University in St. Louis ORCID

Also Known As

D Chamberlain, E BRUNT, E Brunt, E M Brunt, E. Brunt, E. M. Brunt, E.M. Brunt, ELIZABETH BRUNT, ELIZABETH M. BRUNT, Elisabeth M. Brunt

398

Publications

71.5K

Citations

101

H-Index

180

Concepts

All Affiliations

Washington University in St. Louis Saint Louis University Johns Hopkins University University of California San Diego Indiana University – Purdue University Indianapolis

About

Elizabeth M. Brunt is an author at Washington University in St. Louis specializing in medicine, hepatology, and liver physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	56	98	27.1K
2	Health Sciences	31	40	17K
3	Engineering	3	3	522
4	Humanities	1	1	11
5	Language Studies	1	1	397

Elizabeth M. Brunt

196

Publications

51.4K

Citations

H-Index

Page 1

	Year	Citations
Design and validation of a histological scoring system for nonalcoholic fatty liver disease† David E. Kleiner, Elizabeth M. Brunt, Mark L. Van Natta, Hepatology Nafld Activity ScoreDiagnosisPathologyGastroenterologyFatty Liver Disease	2005	10.5K
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions Elizabeth M. Brunt, Christine G. Janney, Adrian M. Di Bisceglie, The American Journal of Gastroenterology	1999	3.8K
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association Naga Chalasani, Zobair M. Younossi, Joel E. Lavine, Hepatology	2012	3.8K
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis Arun J. Sanyal, Naga Chalasani, Kris V. Kowdley, New England Journal of Medicine	2010	3.2K
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial Brent A. Neuschwander‐Tetri, Rohit Loomba, Arun J. Sanyal, The Lancet HepatologyMedicineLiver PhysiologyPathologyPlacebo-controlled Trial	2014	2.2K
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology Naga Chalasani, Zobair M. Younossi, Joel E. Lavine, Gastroenterology ObesityMetabolic SyndromePractice GuidelineMetabolic Associated SteatohepatitisHepatology	2012	1.8K
A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells Ken Cadwell, John Y. Liu, Sarah L. Brown, Nature Autophagy Gene Atg16l1MitophagyCell AutophagyKey RoleAutophagy	2008	1.5K
Nonalcoholic Fatty Liver Disease (NAFLD) Activity Score and the Histopathologic Diagnosis in NAFLD: Distinct Clinicopathologic Meanings §Δ Elizabeth M. Brunt, David E. Kleiner, Laura Wilson, Hepatology	2010	1.2K
Endpoints and clinical trial design for nonalcoholic steatohepatitis Arun J. Sanyal, Elizabeth M. Brunt, David E. Kleiner, Hepatology	2011	749
Nomenclature of the finer branches of the biliary tree: Canals, ductules, and ductular reactions in human livers Tania Roskams, Neil D. Theise, Charles Balabaud, Hepatology Human Reactive LesionsLiver PathologistsOrgan PhysiologyPathologyAnatomy	2004	720

Page 1